Faculty Bios

Paul Brennan

Paul Brennan, PhD

Head of the Genetics Section of the International Agency for Research on Cancer

Paul Brennan, PhD, is the Head of the Genetics Section of the International Agency for Research on Cancer (IARC/WHO), Lyon, France. The research focus of his group has two primary aims (i) identifying cancer predisposition genes through either genotyping or sequencing of very large numbers of cases and controls, and (ii) using biomarkers to help identify non-genetic risk factors for cancer, and even help identify early stage cancers. His group works with colleagues in many different parts of the world, with active field work studies underway in central and eastern Europe, central and south-east Asia, and Latin America.

Pankaj Chaturvedi

Dr Pankaj Chaturvedi MBBS, MS, FAIS, FICS, FACS, MNAMS

Professor and Head and Neck cancer Surgeon at Tata Memorial Hospital, Mumbai

Dr Pankaj Chaturvedi MBBS,MS,FAIS,FICS,FACS,MNAMS is Professor and Head and Neck cancer Surgeon at Tata Memorial Hospital, Mumbai. Dr Chaturvedi did his medical schooling and post graduation in General Surgery at Banaras Hindu University. He was adjudged the best Intern and the best post graduate during his tenure in Banaras Hindu University. Later, he decided to work in field of surgical oncology and received his formal training at Tata Memorial Hospital, Mumbai.

He has been invited as visiting faculty in 22 institutions in 18 countries. He is member of several prestigious national and international organizations and he is reviewer of several leading journals and he is the editor of the Textbook of Head and Neck Surgery. He is the Assistant Editor of the International Journal of Head and Neck surgery. He has authored 6 book chapters and more than 100 papers in international peer reviewed journals.

He is Principal investigator of several clinical trials and his main area of interest is early detection of oral cancer. He is the recipient of the Robert Maxwell Byers award of the American Head and Neck society in year 2010. He was nominated as Council Member of the prestigious International Academy of Oral Oncology. He is one of the founding members of South Asian Federation of Oncology and in the steering committee of the Eurasian Head and Neck Oncology Society. He is the founder and treasurer of the Head Neck Cooperative Oncology Group.

Dr Chaturvedi has tremendous interest in Public Health issue especially related to Tobacco control. He was the coordinator of the Smoke free Mumbai - www.smokefreemumbai.org campaign. He started the famous Voice of Tobacco Victims Campaign (www.vovindia.org ) which has allowed the cancer victims to voice their opinion on the issue of tobacco control. This campaign was instrumental in ban on Gutka all over India and also increase in Tobacco Taxes. He received WHO Director General’s award in 2010 for this campaign.

He represented India as Global Cancer Ambassador to New York to lobby with UN representatives for the special UN summit on Non Communicable diseases. He was awarded Outstanding Young Indian award for his public health initiatives. He was selected as a speaker on behalf of the Civil Society in UN Summit on Non Communicable diseases, 2011 in New York. He is also the recipient of the Judy Wilkenfield Award for excellence in Tobacco Control by Campaign for Tobacco Free Kids, Washington, USA. Recently he was conferred British Medical Journal award popularly known as Oscar of Medicine.

Terry Day

Terrence A. Day, MD

Wendy and Keith Wellin Endowed Chair in Head and Neck Surgery, Professor and Director, Division of Head and Neck Oncologic Surgery, Vice Chair for Clinical Affairs, Department of Otolaryngology, Head and Neck Surgery

Dr. Day received his medical degree from the University of Oklahoma. He completed his residency at Louisiana State University before pursuing a fellowship in head and neck oncologic surgery at the University of California, Davis and in craniomaxillofacial surgery at Inselspital-Bern in Bern, Switzerland. Following fellowship, he joined the faculty in the Department of Otolaryngology-Head and Neck Surgery at Vanderbilt University Medical Center in Nashville, Tennessee and is now Professor, Vice Chair and Director of the Division of Head and Neck Oncologic Surgery in the Department of Otolaryngology-Head and Neck Surgery at the Medical University of South Carolina in Charleston, South Carolina, USA. He also serves as Director of the Head and Neck Tumor Center at the NCI Designated Hollings Cancer Center at MUSC and has a joint appointment in the Department of Craniofacial Biology, Department of Stomatology and College of Graduate Studies.

Dr. Day currently serves as Past President of the American Head and Neck Society and serves on the Council of the International Academy of Oral Oncology while having completed a four-year term on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery. He has served as a Senior Examiner with the American Board of Otolaryngology and has also served on the National Cancer Institute’s Head and Neck Steering Committee, Head and Neck Surgical Subcommittee for RTOG and Head and Neck Working Group for the American College of Surgeons Oncology Group. He was the first chairman of the working committee of the South Carolina Cancer Association. Dr. Day volunteers his time as President of the Head and Neck Cancer Alliance, Inc. and as Treasurer of Charleston Moves and in 1998 started the inaugural international Oral and Head and Neck Cancer Awareness Week (OHANCAW) which is now in its tenth year.

He has been active in both clinical and transitional research as a principal investigator and as co-investigator in over 25 clinical trials. He has been the recipient of numerous research grants and public health related advocacy funding for head and neck cancer. He has edited three textbooks and authored over 100 publications.

Mark DeLacure

Mark D DeLacure, MD

George E. Hall Endowed Chair in Head & Neck Surgery, Chief, Division of Head & Neck Surgery, Associate Professor of Otoloaryngology—Head & Neck Surgery, Department of Otolaryngology—Head & Neck Surgery, Associate Professor of Plastic Surgery, Institute of Reconstructive Plastic Surgery, Department of Plastic & Reconstructive Surgery

Dr. Mark D DeLacure is a native Floridian who received his Bachelor of Science in Biochemistry and Pharmacology from the University of Florida in 1982, followed by his MD degree from the same in 1986. He then trained in General Surgery at the Stanford University School of Medicine in Palo Alto, California from 1986-88 and then in Otolaryngology-Head & Neck Surgery at the Yale University Medical Center 1988-1991. He then served as Fellow in Head and Neck Surgery and Oncology at the Memorial Sloan-Kettering Cancer Center in New York through 1992. This was then followed by the completion of training in Plastic and Reconstructive Surgery at UCLA in Los Angeles, California in 1994.

Dr. DeLacure then joined the faculty of the Roswell Park Cancer Institute in Buffalo, New York and became Chairman of the Divisions of Head & Neck Surgery and Plastic and Reconstructive Surgery. He was recruited to NYU on 1998 and he is currently the George E. Hall Endowed Chair in Head & Neck Surgery and Chief of the Division of Head & Neck Surgery in the Department of Otolaryngology –Head & Neck Surgery, and is Associate Professor of Plastic Surgery in the Institute of Reconstructive Plastic Surgery in the Department of Plastic & Reconstructive Surgery, and Associate Professor of Neurosurgery in the Department of Neurosurgery.

He is a Diplomate of the American Board of Otolaryngology-Head & Neck Surgery and of the American Board of Plastic Surgery.

Dr. DeLacure specializes in reconstructive microsurgery, the treatment of advanced stage and previously-treated head & neck malignancy, open skull base surgery, surgery of the craniocervical junction, cervicothoracic inlet, neurofibromatosis, robotic transoral surgery and surgery of the pharyngoesophageal junction. His research interests focus on clinical techniques and outcomes. He has authored and edited numerous works in multispecialty peer-reviewed journals and texts and has lectured worldwide on various topics of specialty interest. He is a member of multiple professional and subspecialty societies. He has operated in several countries as part of both educational symposia and humanitarian missions.

Pedro Dios

Professor Pedro Diz Dios, MD, DDS, PhD

School of Medicine and Dentistry, Santiago de Compostela University

Pedro Diz Dios is qualified in Medicine and is a Specialist in Stomatology at Santiago de Compostela University (Spain). He trained in Oral and Maxillofacial Surgery at the Klinik für Zahn-, Mund- und Kieferheilkunde at Freiburg University Hospital (Germany), gaining his Doctor of Philosophy PhD (Freiburg University). He is Professor, Consultant and Head of the Special Needs Unit, School of Medicine and Dentistry, Santiago de Compostela University. He was Director of the Stomatology Department (Santiago de Compostela University) and he is Director of the Master's Program on “Dental management of patients with systemic diseases” at the Santiago de Compostela University.

He is a Council member of the Spanish Society of Dentistry for Special Needs Patients (SEOENE) and a Council member of the International Association for Disability and Oral Health (IADH). He is an Honorary Visiting Professor at the UCL-Eastman Dental Institute (London). He is an Associate Editor of “Oral Diseases” Journal, “Medicina Oral Cirugía Oral y Patología Bucal”, as well as of “Journal of Oral and Experimental Dentistry”, and an Editorial Board Member of “Oral Oncology” Journal. He was Director of the Johnson & Johnson Chair for Healthcare Promotion (Santiago de Compostela University). He has written about 150 peer-reviewed papers and co-authored several books.

Joel Epstein

Joel B. Epstein, DMD, MSD, FRCD(C), FDS RCS(E)

Diplomate American Board of Oral Medicine

Dr Epstein is currently Medical Director, Cancer Dentistry at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Health System in Los Angeles, CA and Consulting Staff Member, Otolaryngology and Head and Neck Surgery, City of Hope National Medical Center, Duarte, CA. He conducts a referral practice in Oral Medicine and Oral Oncology (Oralmedicinepacific.com). Dr. Epstein has published extensively in early detection of oral potentially malignant disorders and cancer, oral complications of cancer therapy including mucositis, infection, dry mouth, neurosensory dysfunction including pain and taste dysfunction and broad issues of cancer survivorship, and in general areas of oral medicine.

Camile Farah

Professor Camile S Farah BDSc, MDSc (OralMed OralPath), PhD, GCEd (HE), GCExLead, FRACDS (OralMed), FOMAA, FIAOO, FICD, FPFA

Professor of Oral Oncology, Head, School of Dentistry, University of Western Australia, Director, Oral Health Centre of Western Australia

Professor Camile Farah is Professor of Oral Oncology, Head of the School of Dentistry, and Director of the Oral Health Centre of WA, at the University of Western Australia.

Professor Farah is a registered specialist in both Oral Medicine and Oral Pathology with sub-specialty training in Oral Oncology. He has interests in clinical oral medicine and surgical oral pathology (oral mucosal pathology, salivary gland diseases, orofacial pain), diagnostic head and neck pathology (oral cancer and precancer), and oral and maxillofacial radiology (bone pathology). He maintains a part-time private practice in Oral Medicine, is a member of the Head & Neck Cancer Multidisciplinary Team at the Sir Charles Gairdner Hospital, and Director of the Australian Centre for Oral Oncology Research & Education (ACORE), where he undertakes clinical and translational research into head and neck cancer early detection, molecular diagnostics, and imaging. He is an Associate Editor for Journal of Oral Pathology & Medicine and an Editorial Board member of Oral Diseases.

He is the Past President of the Oral Medicine Academy of Australasia and served as its Inaugural President, Past President of the Australian & New Zealand Division of the International Association for Dental Research, Vice Chairman of the Australian Dental Research Foundation and Past Chairman of its Research Advisory Committee.

Professor Farah has authored 120 peer reviewed publications including 10 book chapters, and has attracted approximately $5 million in competitive research funding. His research interests in oral oncology span optical imaging systems (Optical Fluorescence Imaging and Narrow Band Imaging), molecular genomics (Next Generation Sequencing), and clinical trials in early cancer detection and surgical margin delineation.

Professor Farah has collaborations with industry partners including LED Dental (Velscope), Star Dental (Identafi), Olympus (Narrow Band Imaging), Henry Schein Halas, Colgate Palmolive, Agilent Technologies (microRNA arrays, exome sequencing), and Life Technologies (SOLiD, Ion Torrent, Ion Proton) and works with these companies to extend R&D and clinical use of new products and technology, while also identifying commercialization opportunities for his work specifically in the area of molecular diagnostics.

Silvio Gutkind

J. Silvio Gutkind, PhD

Professor, Department of Pharmacology, Associate Director of Basic Science, UC San Diego Moores Cancer Center

Dr. Gutkind received his PhD in pharmacy and biochemistry from the University of Buenos Aires, Argentina, and after his post-doctoral training at the NIMH and NCI, he joined the NIDCR, NIH, as Chief of the Oral and Pharyngeal Cancer Branch. At the NIH, he led a national and international research program addressing oral cancer until his recent recruitment as Associate Director of Basic Science, UC San Diego Moores Cancer Center. Dr. Gutkind’s research team studies the molecular basis of cancer, with emphasis on basic mechanisms of signal transduction and cell growth control and their dysregulation in human malignancies, with emphasis on oral cancer, AIDS-associated malignancies, and uveal and cutaneous melanoma.

The goal of his research program is to exploit the emerging information on dysregulated signaling circuitries and genomic and molecular alterations to identify new mechanism-based precision therapies to prevent and treat cancer. In particular, Dr. Gutkind has recently led a multi-institutional effort aimed at exploring the clinical benefits of treating newly diagnosed head and neck cancer patients with mTOR inhibitors. As part of a new multidisciplinary team at the Moores Cancer Center, he is now investigating the effectiveness of PI3K/mTOR inhibitors for oral cancer prevention and treatment, as single agents and as part of novel co-targeting strategies, and he is co-leading a new precision prevention medicine trial in oral premalignancy. He has been the recipient of numerous awards, published 3 books and 450 articles, and mentored many junior investigators who are now playing leadership roles in the US and abroad.

Brian Hill

Brian Hill

Brian is currently the Founder and Executive Director of the Oral Cancer Foundation, and is a frequent public speaker on oral cancer issues at universities, professional medical, dental and research conferences, TV news and magazine shows. He is routinely interviewed for oral cancer articles by numerous print media publications as diverse as The Wall St. Journal, USA Today and the Boston Globe, to Men’s Health and Woman's Day Magazines, and is a trusted source for backgrounder material used to prepare major newscasters, writers, and talk show hosts.

A stage four oral cancer survivor, he went though treatments at MD Anderson Cancer Center. That journey’s personal story was featured in USA Today, the largest circulation newspaper in the US and looked at the transformation of a patient into an advocate for others. The powerful emotional components of his path as a patient were again featured in the Lance Armstrong book, LiveStrong: Stories of Survival.

He is the author of articles in professional medical/dental publications on oral cancer screening, opportunities for the reduction of death rates in oral cancer, the changing demographics of the oral cancer population, and HPV viruses and related cancers. He works as a Head and Neck Cancer Advocate on Capitol Hill when issues related arise, and was personally involved with Senator Ted Kennedy and his team, working on the landmark tobacco bill that allowed the FDA to control tobacco for the first time in history that was approved in 2009. He currently sits on two NIH oversight committees one at the National Cancer Institute on Immunotherapy and Head and Neck Cancer, the other at the NIDCR on long-term impacts of oral cancer treatments.

His organization was voted the Best Small Cancer Non-Profit in America in 2009 (regardless of cancer type) by the Great Non-Profits and Guidestar oversight organizations, and has remained in their top 10 list every year since regardless of organization size. The organization is well known for its highly successful programs, one of which is the production and distribution of Pubic Service Announcements (PSA’s) delivered by high profile celebrities, that jointly have received almost 150 million viewer impressions during their run on major TV networks. OCF has received many awards and accolades. A few of which are;

  • The Strusser Award from New York University for public service. Previous recipients include surgeon generals, founder of the special Olympics, and numerous celebrity activists like Blythe Danner and Jack Klugman.
  • Award for excellence in public service from the National Institute of Health/NIDCR, presented at the Washington Press Club
  • George C. Cushing Award for public service, Chicago Dental Society
  • First non doctor given a membership in the American Academy of Oral Medicine
  • Survivors Circle Award for Public Service from ASTRO (American Society of Treating Radiation Oncologists) and was honored for patient support activities at their annual National meeting
  • The Oral Cancer Foundation (which he founded and administrates) was given the 2009 Cancer Fighters Award, being chosen as the best small cancer non-profit (regardless of cancer type) in the US by Great Non-Profits Inc, in cooperation with Guidestar, two non-profit oversight organizations.

He is a strong believer in strategic alliances to facilitate maximum change, and to that end has been invited and is engaged with many different organizations that are stake holders in the oral cancer issue.

  • American Society of Clinical Oncology, member
  • International Academy of Oral Oncology, member
  • American Academy of Oral Medicine, member
  • Centers for Disease Control (CDC), Oral Cancer Work Group
  • HPV Awareness.org, founding member of this international effort
  • College of American Pathologists, HPV testing guideline group, member
  • American College of Prosthodontics, Oral Cancer Task Force, member
  • International Consortium on Head and Neck Cancer Awareness, member
  • International Association for Dental Research, member
  • American Academy of Oral & Maxillofacial Surgery, Oral Cancer Task Force, member
  • American Public Health Association, member
  • Bruce Paltrow Oral Cancer Fund (Administrator)
  • The Armstrong Foundation Grant Review Committee (past member)
Jos Hille

Jos Hille, DDS, M.Dent, FC PATH SA

Professor, Chair of Discpline, Chief Pathologist

Jos Hille is an oral & maxillofacial/head& neck surgical pathologist with 30 years of experience as diagnostician, post- and undergraduate trainer & lecturer, academic programs director & developer, administrator and researcher. His favorite diagnostic activities are in the areas of head & neck cancer, salivary gland tumors, bone pathology and clinical oral mucosal diseases.

His primary research interests are in epidemiology of head & neck cancer in (southern) Africa and translational research in the practical diagnosis of early oral cancer using liquid-based cytology.

Jos completed his primary undergraduate dental degree in the Netherlands in 1982 after which he specialized with a clinical master’s degree in Oral Pathology at the University of the Witwatersrand (1986). He has been affiliated with the University of the Western Cape since 1988 and the WHO Collaboration Centre for Sub-Saharan Africa (portfolio oral cancer) since the early 90’s. Jos completed a one-year fellowship/visiting professorship in Advanced Oral Pathology and Head & Neck Pathology at Mount Sinai Medical Center in New York between 1999 and 2003. He obtained his fellowship with the College of Pathology of South Africa in 2003.

Jos is actively engaged in training Oral & Maxillofacial pathologists for South Africa and Africa; already two African trainees (Zimbabwe/Zambia) and Sudan have qualified and two more residents from Ghana and Kenya each are currently training to become specialists in their respective countries. He is an active member of the International Association of Oral Pathologists and its newly established African division.

Honghua

Honghua DDS, PhD

Professor and Chair of the Department of Oral Medicine at Peking University, School of Stomatology

Dr. Hua is the professor and Chair of the Department of Oral Medicine at Peking University, School of Stomatology. She received her DDS at Xian Medical University in 1988. She then completed her PhD program at the Beijing Medical University in 1992. Dr. Hua has studied as visiting scholar at University of California, San Francisco School of Dentistry during 1999-2000.

She currently serves as President-elect of Academy of Integrated of Traditional Chinese Medicine and Western Medicine in Dentistry, Chinese Stomatological Association

Prof. Hua has a wide range of academic interests : Oral mucous membrane diseases and correlation with systemic diseases, Epidemiology of OPMD and oral cancer, Biomarkers of early diagnosis, prognosis and therapeutic outcome of OPMD and Oral cancer.

Dr. Hua has published more than 80 scientific articles and 20 book chapters, and edited 5 books.

Jed J. Jacobson

Jed J. Jacobson, DDS, MS, MPH

Chief Science Officer and Senior Vice President, Professional Services, Delta Dental of Michigan, Ohio, Indiana and North Carolina

Dr. Jed J. Jacobson is chief science officer and the senior vice president of Professional Services of Delta Dental of Michigan, Ohio, Indiana, and North Carolina. In this position, Dr. Jacobson oversees the administration of Professional Relations and Professional Review, and directs Delta Dental’s Research and Data Institute, which is dedicated to the application of scientific evidence to improve dental plan design. Dr. Jacobson is an expert in dental research whose areas of focus include the linkage between oral and systemic health, the cost-effectiveness of dental services, and personalized medicine. Prior to joining Delta Dental in 2001, Dr. Jacobson was an associate professor, assistant dean for community and outreach programs and interim chair of oral medicine, oral pathology and oral oncology at The University of Michigan School of Dentistry. He also served The University of Michigan School of Dentistry in a variety of academic appointments.

Dr. Jacobson is an adjunct clinical associate professor at the University of Michigan School of Dentistry and was appointed to Michigan State University’s College of Human Medicine in 2012.

Dr. Jacobson earned a Bachelor of Science degree from Michigan Technological University, a D.D.S. degree from The University of Michigan, a master’s degree (M.S.) in oral diagnosis-radiology from The University of Michigan, and a master’s degree (M.P.H.) in health service administration from the University of California, Los Angeles. He operated general dentistry practices in Livonia and Ann Arbor, Michigan.

Ross Kerr

Dr. Ross Kerr

Chair of the organizing committee for the Global Oral Cancer Forum

Dr. Ross Kerr is chair of the organizing committee for the Global Oral Cancer Forum. He received his DDS from McGill University in Montreal, Canada, and his MSD and certificate in Oral Medicine at the University of Washington. He is a Diplomate of the American Board of Oral Medicine and Clinical Professor in the Department of Oral & Maxillofacial Pathology, Radiology & Medicine at New York University College of Dentistry where he is the director of the Oral Mucosal Disease Service and an attending at the NYU Oral Cancer Center. He is the President of the American Academy of Oral Medicine and a steering committee member of the World Workshop on Oral Medicine. He serves as a member of the Scientific Advisory Board for the Oral Cancer Foundation.

His research experience includes the evaluation of current and emerging technologies for the early detection of oral cancer. He has lectured nationally and internationally on oral cancer, dry mouth, and other oral medicine related topics, and has contributed to the dental and medical literature. His private practice is focused on the management of patients with oral mucosal disease, dry mouth, and the dental management of medically complex patients.

Omar Kujan

Dr. Omar Kujan, DDS, DipOPath, MSc, PhD

Dr. Kujan received his PhD degree from the University of Manchester, School of Dentistry in 2006. The title of his thesis was “Studies on Screening and Prognosis of Oral Cancer and Precancer”. He was then appointed by the University of Manchester as a Clinical Research Fellow to develop and assess an innovative oral cytobrush "Orcellex". He took a training post at Oral Pathology Department, Guy's Hospital, London, UK. He is currently an assistant professor in oral pathology and medicine at the department of Oral Medicine and Diagnostic Sciences, and director of Skills Development and Continuing Education Unit, Al-Farabi College for Dentistry and Nursing, Riyadh, Saudi Arabia. He previously was a senior lecturer in the Department of Oral Pathology at Al-Baath University, Syria, and head of department.

He has over 50 publications in peer review international journals, in addition to several book chapters and other publications on the topics of oral cancer, oral potentially malignant disorders, oral diseases and dental education. He also has served as a reviewer for several prestigious peer review journals. Among his academic endeavors, he was a reviewer of the group II at the World Workshop on Oral Medicine VI that convened oral medicine experts from around the world in Orlando, 2014. In addition, he contributed to the activities of the Global Oral Cancer Forum, 2016 as a delegate to the Middle East Region in two themes.

Moni Abraham Kuriakos

Moni Abraham Kuriakose MD, FDSRCS, FFDRCS, FRCS Ed., FRCS

Professor and Director, Dept. of surgical Oncology, Chief, Head and Neck Oncology Service, Mazumdar-Shaw Cancer Center, Director, Mazumdar-Shaw Center for Translational Research, Narayana Health City, Bangalore, India

Moni Abraham Kuriakose, is Professor and Director of Department of Surgical Oncology and Chief of Division of Head and Neck Oncology of Mazumdar Shaw Cancer Center, Bangalore. He was professor and vice chairman of Department of Head and Neck/Plastic and Reconstructive Surgery at the Roswell Park Cancer Institute, Buffalo, New York. Dr. Kuriakose has held many national and international leadership positions, including president of Indian head and neck oncology association, member AO research review commission and former Secretary General of the International Academy of Oral Oncology. Dr. Kuriakose’s research group focuses on early detection and chemoprevention of head and neck cancer and understanding mechanism of treatment resistance. He is principal investigator of two NIH grants and eight government of India sponsored research projects. He has authored of over 150 peer-reviewed publications and four volume text book “contemporary oral oncology”

Special Interest:

  • Skull base surgery
  • Oral cavity cancer
  • Head and Neck Reconstruction
  • Early detection and prognostication markers
  • Molecular profiling of cancer
Hector Lanfranchi

Prof. Hector Eduardo Lanfranchi Tizeira

Head Professor of the Oral Medicine Department at the UBA School of Dentistry

Dr Hector Lanfranchi graduated from the School of Dentistry of the National University of Córdoba, Argentina. He joined the School of Dentistry of the University of Buenos Aires (UBA), and became a specialist in Oral Pathology in 1981. He was appointed Head Professor of the Oral Medicine Department at the UBA School of Dentistry in 1991, and continues to hold the position today. Between 2006 and 2013 he was Councilor of the UBA, advising junior researchers, teaching postgraduate students and tutoring. He is Honorary Professor at the School of Dentistry of the University of Córdoba, his home university. He was Director of the Oral AIDS Center at the UBA School of Dentistry from 1993 to 1998. In 1992 he was appointed NIH Fellow of the University of Texas.

He has been Director of the NIH Sjögren's International Clinical Collaborative Alliance for Latin America since 2003. He was Board Member at Large of the International Association for Dental Research from 2001 to 2005. At present, he continues working with the IADR, where he is Founder and President of the International Association for Dental Research for Latin American Region, and conducts an annual Prevention Oral Cancer Campaign across Argentina and several countries in Latin America. His lecturing activities include courses and conferences in numerous countries including Argentina, Chile, Uruguay, Colombia, Brazil, Spain, the USA, Venezuela, Peru, Paraguay, Panama and Ecuador. He is author of a number of scientific papers published in local and international peer reviewed journals.

Calum MacAulay

Calum MacAulay, PhD

Born in Halifax, Dr. MacAulay has lived and worked in Vancouver for over 25 years. His formal training includes a BSc in Engineering Physics (1982) from Dalhousie University, an MSc in Physics (1985) from Dalhousie University, and a PhD in Physics (1989) from the University of British Columbia. Dr. MacAulay is also currently an Associate Member of the Department of Physics and Astronomy and a Clinical Associate Professor in the Department of Pathology at the University of British Columbia. He has been awarded i) the BC Lung Association Scholar (1990-1995), ii) the Friesen-Rygiel Prize for outstanding Canadian academic discovery leading to uniquely positioned commercialization opportunities (1999), and iii) the Young Innovator Award, BC Science and Technology Award, Science Council of BC (1999).

Marco Meleti

Professor Marco Meleti, DDS, PhD

Department of Biotechnological, Biomedical and Translational Sciences, Dental School – University of Parma, Italy

Marco Meleti graduated from Dental School at the University of Parma (Italy) in 2002 and took a two-year internship in Oral Pathology and Medicine under the supervision of Prof. Paolo Vescovi at the Department of Head and Neck Sciences of the University Hospital of Parma.

From 2004 to 2006 he worked at the Department of Oral and Maxillofacial Surgery/Oral Pathology of the Free University Medical Center/ ACTA in Amsterdam, The Netherlands, where he earned his PhD in 2008 under the supervision of Prof. Dr. Isaäc van der Waal. In 2007 he took a one month internship in Oral Medicine at the Department of Oral Medicine of the University of San Francisco, California, under the supervision of Prof. Sol Silverman.

He has been appointed Consultant Professor at the University of Parma in 2009.

From 2010 to 2014 he has been the General Secretary of the European Association of Oral Medicine (EAOM).

At present he teaches Oral Surgery and Clinical Dentistry at the University of Parma, where he also coordinates the post-graduate Master Program in Oral Surgery and Oral Medicine.

His main research interests include the potentially malignant disorders of the oral mucosa, the pathogenesis of oral cancer and the new technologies in oral surgery. He is author and co-author of 54 scientific papers on peer-reviewed international journals with impact factor and of approximately 100 scientific papers on Italian scientific Journals. He is author and co-author of several books of oral medicine and oral surgery.

Matthew Myers

Matthew L. Myers

President of the Campaign for Tobacco-Free Kids

Matthew L. Myers is President of the Campaign for Tobacco-Free Kids. The Campaign for Tobacco-Free Kids is a leading force in the fight to reduce tobacco use and its deadly toll in the United States and around the world. In 1996, Mr. Myers helped to found the Campaign for Tobacco-Free Kids.

In the United States and around the globe, the Campaign advocates at all levels of government for policies that reduce tobacco use and save lives, and supports governments and non-governmental organizations in promoting and implementing these policies. The Campaign is a partner in the Bloomberg Initiative to Reduce Tobacco Use, which focuses on low- and middle-income countries where more than 80 percent of tobacco-related deaths will occur in the coming decades

Over the last 25 years, Mr. Myers has participated in virtually every major US tobacco-related legislative effort, including the efforts that revised the warning labels on cigarettes in 1984, eliminated tobacco subsidies, required warning labels on smokeless tobacco and banned smokeless tobacco from advertising on TV and radio in 1986, the ban on smoking on airplanes, multiple tax increases, the lawsuits brought by the US States against the tobacco industry and the legislation that granted the US Food and Drug Administration broad authority over tobacco products. Internationally, My Myers and the Campaign worked on the development of the WHO Framework Convention on Tobacco Control, the first global public health treaty and are now working in countries across the globe for the implementation of the policies called for by the treaty.

In 1999 Mr. Myers was appointed to serve on the first tobacco advisory committee to the Director General of the World Health Organization. In 2000, he was named by President Clinton to co-chair a Presidential Commission to develop a proposal to both address the economic problems being experienced by tobacco farmers and at the same time promote the public health through a reduction in tobacco use. In 2011 he was selected to serve on the Civil Society Task Force to advise the President of the General Assembly of the UN in conjunction with the UN High Level Meeting on Non-Communicable Diseases.

In 1989, Mr. Myers received the prestigious Surgeon General’s Medallion from Dr. C. Everett Koop for contributions to the public health. In 2004, the Harvard School of Public Health bestowed its highest award, the Julius B. Richmond award, on Mr. Myers for his work. In 2006 the Campaign for Tobacco-Free Kids received the Luther Terry Award for its leadership on global tobacco control. In 2007, the American Cancer Society honored Mr. Myers with its highest award, The Medal of Honor.

Mr. Myers is a graduate of the University of Michigan Law School. He began his tobacco control work in 1980 when he joined the Federal Trade Commission and was responsible for the agency’s tobacco-related activity. From 1981 to 1996 he was a partner in the law firm of Asbill, Junkin and Myers. From 1982 to 1996, he also represented the Coalition on Smoking OR Health, an organization comprised of the American Cancer Society, the American Lung Association, and the American Heart Association.

Toru Nagao

Toru Nagao DDS, PhD, DMSc

Professor and Director, Department of Oral and Maxillofacial Surgery, Okazaki City Hospital, Japan

Dr. Toru Nagao is Chief Maxillofacial Surgeon, Okazaki City Hospital, Japan. He practices the full scope of oral and maxillofacial surgery. His specialties are surgical oncology for oral cancer and precancer as well as management of oral and maxillofacial diseases. Besides his clinical expertise, he has been active in the areas of early detection and prevention for oral cancer. Dr. Toru is Senior Research Fellow, WHO Collaborating Centre for Oral Cancer / Oral Medicine & Experimental Oral Pathology, Guy’s, King’s & St. Thomas’ Dental Institute, London. He was a medical expert of Japan International Cooperation Agency (JICA) from 2001 to 2007 and appointed as a Chief Advisor to Dental Education Project in Sri Lanka.

Dr. Toru is an executive member of Asian Society of Oral and Maxillofacial Surgeons. He has been appointed as Visiting Professor of Fujita Health Science University School of Medicine and Clinical Professor of Faculty of Medicine of Shimane University. Dr. Toru is starting to conduct a nationwide multicenter tobacco cessation intervention study in patients with tobacco related oral lesions in Japan as a principal investigator.

Hiroshi Ogawa

Dr Hiroshi Ogawa DDS, MDSc, PhD

Dental Officer, Global Oral Health Programme, World Health Organization (WHO)

Dr Hiroshi Ogawa acquired his dentist qualifications at the Nihon University in Japan, his Masters in Public Health Dentistry at the University of Sydney in Australia and his PhD in Preventive Dentistry at Niigata University in Japan. He has been Associate Professor at the Graduate School of Medical and Dental Sciences and also Vice-Director of WHO Collaborating Centre for Translation of Oral Health Sciences at Niigata University.

Dr Ogawa has been working with WHO since 2003 in different capacities. Based on a secondment between WHO and the Japanese university consortium supported by the Japanese government, Dr Ogawa has been seconded as Dental Officer to work with the WHO Oral Health Programme in Geneva HQ as of 2014.

Kannan Ranganathan

Dr. Kannan Ranganathan, BDS, MDS, MS (oral path), PhD, FIAOMP

Professor & Head, Department Of Oral & Maxillofacial Pathology Ragas Dental College and Hospital, President Indian Association of Oral and Maxillofacial Pathologists, Councilor Asia International Association of Oral Pathologists, Secretary-General Asian Society of Oral and Maxillofacial Pathology

Completed Masters in Oral Pathology from The Dr.MGR Medical University, Chennai, India in 1990 and went on to obtain Certificate of training and Masters in Oral Pathology from The Ohio State University, USA in 1996. Passed the fellowship examination of the American Academy of Oral and Maxillofacial Pathology in 1996. Was conferred PhD in 2010 by The Dr.MGR Medical University, Chennai, India.

Currently held appointments include of Visiting Professor (2015-2016) to the Department of Oro-Maxillofacial Surgical and Medical Sciences, Faculty of Dentistry University of Malaya; Chair, Fellowship Committee of Indian Association of Oral and Maxillofacial Pathologists and Clinical Consultant for YRG Centre for AIDS Research, Chennai and TTK Centre for substance abuse rehabilitation, Chennai

Areas of research interest: Cancer-Precancer, Stem cells and HIV/AIDS

Alexander Rapidis

Alexander D. Rapidis, PhD.

Alexander D. Rapidis studied Dentistry and Medicine at the University of Athens, Greece, and received his PhD in Oral Medicine and Pathology from the same university. After training in Oral and Maxillofacial Surgery at the University of London, UK, he became an Honorary Lecturer in Oral and Maxillofacial Surgery at King’s College Hospital Medical School, London. Since 1990, Professor Rapidis has been Chairman of the Department of Head and Neck / Maxillofacial Surgery in the Greek Anticancer Institute, “Saint Savvas Hospital”, Athens. He was elected Assistant Professor of Oral and Maxillofacial Surgery at the University of Athens in 2000, an Honorary Senior Lecturer in Maxillofacial Surgery at Eastman Dental Institute, University College London, UK in 2004, and Adjunct Professor in the Department of Diagnostic Sciences and Pathology at the University of Maryland Dental School, Baltimore, USA in 2007.

In August 2007 he was appointed Hon. Professor in Maxillofacial Surgery at Eastman Dental Institute, University College London. He is also Chairman of the Comprehensive Multidisciplinary Therapeutic Management Team in head and neck cancer of the Greek Anticancer Institute, “Saint Savvas Hospital”, Athens. He is the President of International Academy of Oral Oncology (IAOO) and Secretary General of the International Federation of Head and Neck Oncologic Societies (IFHNOS).

Miriam Rosin

Miriam Rosin, BSc (Hons), PhD

Director of the BC Oral Cancer Prevention Program (BCOCPP), BC Cancer Agency, Clinical Professor, Pathology & Laboratory Science, University of British Columbia, Professor, Biomedical Physiology, Simon Fraser University

Dr. Rosin is a translational scientist who has worked across the continuum of care for oral cancer control. As director of the BC Cancer Agency’s oral-cancer program, her work covers a wide variety of topics including development of strategies for increasing public awareness of oral cancer, the engagement and empowering of screening and referral networks for dental health professionals, and the development of clinical models for the risk assessment and management.

She is PI on a unique Oral Cancer Prediction Longitudinal Study that has been following ~ 900 patients with oral dysplasia for over 10 years, to develop and validate indicators of risk of progression for such lesions. This effort has created a pipeline for research into the development of innovative molecular and adjunctive tools to facilitate clinical decision-making and remove barriers to oral cancer and precancer patient flow through the health system.

Her current efforts include the development of a framework for future community cancer prevention research that will provide a venue for the tailoring of these validated approaches within community settings and for catalyzing research at the community level. Dr. Rosin has led cancer research projects in the Philippines, India, Egypt and Russia as well as Canada and is a strong advocate for international collaboration on cancer control. She is currently involved in an international study with investigators at the University of Heidelberg to better define the role human papillomavirus infection plays in progression of oral dysplasia.

Richard Schwarz

Richard Alan Schwarz, Ph.D.

Research Scientist, Department of Bioengineering, Rice University, Houston, Texas, USA

Richard Schwarz is a Research Scientist at Rice University, where he also received the Ph.D. degree in Bioengineering. He worked in the laser industry on the development of Ti:sapphire lasers, Nd-based laser systems, and optical parametric oscillators for applications including remote sensing, communications, and hypersonic wind tunnel diagnostics. His current research interests are in the development and clinical translation of optical technologies for early detection of cancer. He is author or coauthor of twenty peer-reviewed journal articles, more than forty conference abstracts, and three book chapters. He has taught courses in biomedical optics instrumentation and global health technologies at the University of Texas and at Rice University.

James Sciubba

James J. Sciubba

Jim Sciubba was raised in New Jersey, where he attended Fairleigh Dickinson University on a sports scholarship. After receiving his B.S. and D.M.D. degrees at Fairleigh Dickinson University. Following an internship in General Dentistry and military duty, he was granted a P.H.S. fellowship and received a Ph.D. degree in Pathology from the University of Illinois in 1974, followed by a Fellowship in Oral & Maxillofacial Pathology at the ADA, and later earned Diplomate status in that specialty.

Following a 16 year tenure as Chair of Dental Medicine he was granted Emeritus status at Long Island Jewish Medical Center and Stony Brook University, He was then recruited as Professor in the Departments of Otolaryngology, Head & Neck Surgery, Pathology and Dermatology within The Johns Hopkins School of Medicine, and served as the Director of Dental and Oral Medicine at The Johns Hopkins Hospital. Following his retirement from Johns Hopkins he established a clinical practice in Oral Medicine in Timonium, MD where he continues to practice. He also serves at The M.J. Dance Head & Neck Center as a clinical consultant and also functions in a didactic capacity with the rotating Otolaryngology residents from the Johns Hopkins Otolaryngology program in Baltimore.

His contributions to the literature include over 200 peer reviewed papers, book chapters, and abstracts, plus he has authored, co-authored and edited seven textbooks, including the Textbook of Oral Pathology, which is in its 7th edition. He has lectured in North and South America, Asia and Europe, remains active as a reviewer for several journals and is a current or former member of several editorial advisory boards including Oral Oncology, JOMS, IJOMS, The Compendium, “Triple O”, and several ad hoc reviewer assignments. He is also a Past President of The American Academy of Oral and Maxillofacial Pathology, and has served for several years on The National Board Testing Commission at the ADA.

Jatin Shah

Jatin P. Shah, MD

Professor of Surgery at Cornell University Medical College, Elliott W. Strong Chair in Head and Neck Oncology at Memorial Sloan Kettering Cancer Center

Jatin P. Shah, M.D. is Professor of Surgery at Cornell University Medical College and holds The Elliott W. Strong Chair in Head and Neck Oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. He graduated from MS University in Baroda, India, and trained in surgical oncology and Head and Neck Surgery at MSKCC.

In addition to his superlative patient care , Dr. Shah is an international leader in the field of head and neck surgery. He has delivered over 1,200 scientific presentations worldwide, over 80 eponymous lectures, and published more than 550 peer reviewed articles and 10 medical textbooks. He has served as president of The New York Cancer Society, The New York Head and Neck Society, The Society of Head and Neck Surgeons, The North American Skull Base Society and the International Academy of Oral Oncology. He founded The International Federation of Head and Neck Oncologic Societies (IFHNOS), and serves as its CEO.

He is listed amongst the Top Doctors in USA directories for 55 times in last 20 years. He was awarded Honorary Fellowships from The Royal College of Surgeons of Edinburgh, London and Australia, Honorary Ph.D. degrees from Belgium and Greece, Honorary D.Sc, from India, the Blokhin Gold Medal from Russia and the Ellis Island Medal of Honor from the USA. In recognition of his outstanding contributions to enhance patient care and physician training in head and neck surgery, Dr. Shah has received numerous awards, including an eponymous lecture established in his name by IFHNOS , an academic symposium in his name by the American Head and Neck Society, and an endowed chair in his name established by MSKCC.

Paul Speight

Prof. Paul M Speight

Professor in Oral and Maxillofacial Pathology at the School of Clinical Dentistry, University of Sheffield

Paul Speight is Professor in Oral and Maxillofacial Pathology at the School of Clinical Dentistry, University of Sheffield. He is a diagnostic pathologist with special expertise in head and neck cancer and salivary gland tumours.

He is a Past-President of the British Society for Oral and Maxillofacial Pathology, the International Association of Oral Pathologists and of the British Society for Oral and Dental Research. From 2003 to 2008 he was Editor-in-Chief of Archives of Oral Biology and he sits on 5 Editorial Boards. He has served on numerous national and international committees including for IADR, REF2014, NIHR, and Health Education England. He is current Chair of the Scottish Dental Academic Board, and of the Research Committee and the Awards Committee at the Faculty of Dental Surgery, RCS Eng.

His main research interests are in the field of oral cancer, including biomarkers and studies to evaluate early detection and screening in primary care. He has received a number of awards including a Distinguished Scientist Award from the International Association for Dental Research (2008), Award for Outstanding Leadership, Achievement and Dedication (American Academy of Oral and Maxillofacial Pathology, 2008), Senate Award for Excellence in Leadership (University of Sheffield, 2012) and the David L Turpin Award for Evidence-based Research (American Journal of Orthodontics and Dentofacial Orthopedics, 2015). He has published over 220 original research papers as well as a number of books and book chapters.

Wanninayake Tilakaratne

Wanninayake M Tilakaratne BDS, MS, FDSRCS, FRCPath, PhD

Dean and Chair Professor of Oral Pathology. President Elect; International Association of Oral Pathologists, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka

WM Tilakaratne is the Dean and Chair Professor of Oral Pathology, Faculty of Dental Sciences University of Peradeniya, Sri Lanka. His main research interests are molecular Pathology of oral cancer and precancer especially oral submucous fibrosis, diagnostic histopathology of oral lesions, especially salivary and odontogenic tumours.

Professor Tilakaratne has worked as the Professor of Oral Pathology, Queen Mary University of London, visiting Professor to University of Otago New Zealand, University of Malaya in Malaysia and University of Niigata Japan. He is a founder member of the Asian Society of Oral and Maxillofacial Pathology and IAOP councillor for Asia (2008-2012). Currently he is the President Elect of the International Association of Oral Pathologists. He has been an associate editor or editorial board member in more than eight international journals. He has contributed to more than 100 peer-reviewed publications and 12 book chapters in internationally published text books. He has also published a text book on Oral Pathology and Medicine. He is a member of different national committees on research and development and health.

Pablo Vargas

Prof. Pablo Agustin Vargas, DDS, MSc, PhD, FRCPath

Department of Oral Diagnosis, Piracicaba Dental School, UNICAMP, Piracicaba, Brazil

Dr Vargas is a dental graduate of the UNESP-Araraquara-Brazil and obtained a Master of Science and PhD titles in Oral Pathology (UNICAMP-Piracicaba-Brazil). He was chairman of the graduate programme of Estomatopatologia (Oral Pathology and Oral Medicine-UNICAMP) for 4 years (2000-2004). He was Honorary Senior Lecturer of the Department of Oral Pathology of The University of Sheffield-UK (2005-2007). He was vice-chair of the Department of Oral Diagnosis-UNICAMP (2007-2010) and was IAOP Councillor for Latin America and the Caribbean (2008-2012). He was the Chair of Local Organising Committee 16th IAOP and SOBEP Joint Meeting (São Pedro, Brazil-2012). He is a member of the International Association of Oral Pathologists (IAOP) and Brazilian Society of Oral Medicine and Oral Pathology (SOBEP).

He has authored or co-authored 181 scientific papers (145 indexed in PUBMED, Vargas PA, 2370 citations – Google Scholar). He belongs to the Editorial Board of 1- Oral Surgery Oral Medicine Oral Pathology Oral Radiology, 2- Medicina Oral Patologia Oral y Cirurgia Bucal, and 3-Oral Oncology. He was granted with FRCPath (Fellow The Royal College of Pathologists-UK) in January-2013 and Extraordinary Professor at University of Pretoria-South Africa (April 2014 to date). He concluded the supervision of 10 MSc students, 10 PhD and 02 post-doctorate. He also got research grants from FAPESP, CNPq and CAPES (Brazilian Research Funds). He was the Educational Dean of Piracicaba Dental School-Brazil (2010 to 2014) and has been working as Professor and diagnostic pathologist of oral and maxilofacial lesions in Piracicaba Dental School-UNICAMP.

Alessandro Villa

Alessandro Villa, DDS, PhD, MPH

Associate Surgeon, Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard School of Dental Medicine

Dr. Alessandro Villa is an Associate Surgeon in the Division of Oral Medicine and Dentistry at Brigham and Women's Hospital and Dana Farber Cancer Institute. He also holds an appointment at the Harvard School of Dental Medicine where he serves as the Program Director of the Oral Medicine Residency program. Dr. Villa obtained his DDS degree and a PhD from Italy. He served as a post-doctoral fellow at the National Cancer Institute, where he studied the oral HPV prevalence in a large population and methods of early detection of oral cancer. He obtained his Master of Public Health from AT Still University, MO and his Certificate in Oral Medicine from the BWH/HSDM. Dr. Villa's research interests are focused primarily on the early diagnosis of oral cancer and oral complications from cancer treatment. His clinical interest includes treatment of oral mucosal diseases, salivary gland disorders and oral complications from cancer therapy. Dr. Villa teaches in the clinic as well as in class

Michael Walton

Michael Walton, NDD, ATD, MBE

Founder/Chair, The Ben Walton Trust, Registered charity SC 024990

Mike Walton was born in Slough, Bucks, UK during WW2. Secondary education was at Drax Grammar School, West Yorkshire, where he was a boarding pupil.

Trained as an Artist and Designer at Lincoln College of Art and Kingston University he continued to train as teacher and lecturer at Moray House College, Edinburgh.

He has worked variously as an artists agent, in London, also there as a stage and properties designer.

Moving to Scotland he worked in both secondary and higher education as an art and design lecturer. He was Director of First Year Studies, at Edinburgh College of Art for twenty years.

Retiring early, twenty years ago, on the death of his son Ben, from mouth cancer at the age of 22. He set up The Ben Walton Trust in honour of Ben and the remarkable way he coped with his illness, saying, “something must be done about this, how can, what appears to be, a simple mouth ulcer, go on to kill a year later”. After a wide range of research into the subject and writing numerous letters, Mike was shocked to find that the disease was described as a late middle-age male disease, caused principally by smoking and or drinking inappropriately, yet hearing of more and more otherwise healthy and fit young men and women being affected. The disease appeared to be increasing and changing.

Please see website for further information. www.benwaltontrust.org

Saman Warnakulasuriya

Saman Warnakulasuriya OBE, BDS, FDSRCS (Eng & Edin), Dip Oral Med, PhD (Glasg), DSc

Professor Saman Warnakulasuriya has served King’s College London, its associated schools and the NHS Hospitals based at King’s and Guy’s for 23+ years, He was appointed to the chair in Oral Medicine and Experimental Pathology at King’s in 2005. He is a dedicated teacher and a clinician and above all a leading researcher on oral cancer, having conducted several oral cancer screening programs, coordinated the largest study on oral cancer in young people in South East England and detailed studies on biomarkers and adjunctive aids for the early detection.

Professor Warnakulasuriya has published over 240 full research papers based on many collaborative research he conducts globally, lectured extensively at international conferences, particularly focused on oral cancer from the levels of basic science to the management.

He is also the Director of the World Health Organisation (WHO) Collaborating Centre for Oral Cancer (2005-2017). As the Director of WHO CC he works on an honorary capacity as an advisor to WHO member countries on cancer control and carcinogens.

His text book on Oral Medicine and Pathology is popular among post graduates in many dental schools, and with European partners has produced an e learning website on oral cancer www.oralcancerldv.org translated to several European languages.

Recent honours received by Prof Warnakulasuriya include being the 2014 recipient of the Distinguished Scientist Award for Oral Medicine and Pathology Research (IADR) and an OBE from the Majesty the Queen of the United Kingdom for services to Medicine & Health care.

Over four decades he has mentored many trainees and colleagues and is an acknowledged teacher / guest speaker at many forums.